Takashi Iwai

ORCID: 0000-0002-1398-3152
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nuclear Materials and Properties
  • Nuclear reactor physics and engineering
  • Neuropeptides and Animal Physiology
  • Molten salt chemistry and electrochemical processes
  • Pain Mechanisms and Treatments
  • Pharmacological Receptor Mechanisms and Effects
  • Receptor Mechanisms and Signaling
  • Pharmacological Effects of Natural Compounds
  • Radioactive element chemistry and processing
  • Fusion materials and technologies
  • Thermodynamic and Structural Properties of Metals and Alloys
  • Stress Responses and Cortisol
  • Glycosylation and Glycoproteins Research
  • Neuroscience and Neuropharmacology Research
  • Advanced MIMO Systems Optimization
  • Wireless Communication Networks Research
  • Extraction and Separation Processes
  • Metallurgical Processes and Thermodynamics
  • Nuclear materials and radiation effects
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Ion channel regulation and function
  • Hereditary Neurological Disorders
  • Nuclear and radioactivity studies
  • Advanced Wireless Communication Techniques
  • Advanced Wireless Network Optimization

Kitasato University
2015-2024

Pharmac
2019-2023

Tokyo University of Science
1974-2022

Saiseikai Shimonoseki General Hospital
2016-2018

Osaka University
2017

National Institute of Mental Health
2011-2014

National Center of Neurology and Psychiatry
2010-2014

Japan Atomic Energy Agency
2001-2014

Panasonic (Japan)
2009-2013

Advanced Science Research Center
2005

Abstract Aim We previously reported that oxytocin, a peptide hormone, can reverse the β‐amyloid (25–35) (Aβ 25–35 )‐induced impairments of murine hippocampal synaptic plasticity. In this study, we examined effects oxytocin on Aβ ‐induced impairment cognitive behavior in order to investigate potential as clinical treatment tool for Alzheimer's disease (AD). Methods The Y‐maze and Morris water maze (MWM) tests were performed. Since intracerebroventricular (ICV) administration is both invasive...

10.1002/npr2.12292 article EN cc-by Neuropsychopharmacology Reports 2022-09-19

Sonazoid is a new contrast agent for ultrasonography (US). Contrast-enhanced (CEUS) using enables Kupffer imaging, which improves the sensitivity of hepatocellular carcinoma (HCC) detection. However, there are no studies on cost-effectiveness HCC surveillance Sonazoid. We constructed Markov model simulating natural history HCV-related liver cirrhosis (LC) patients, and compared three strategies (no surveillance, US CEUS surveillance). The transition probability cost data were obtained from...

10.1111/j.1872-034x.2011.00936.x article EN Hepatology Research 2012-01-03

Glucagon‐like peptide‐1 (GLP‐1) is derived from the processing of proglucagon in intestinal L‐cells and releases insulin pancreatic β‐cells as an incretin. The GLP‐1 receptor has been proposed a possible therapeutic target for treatment Alzheimer's disease, which neuroinflammation critical pathogenesis. present study investigates whether (7–36) amide, active fragment GLP‐1, protected against synaptic impairments induced by inflammation‐related injurious agents (lipopolysaccharide [LPS],...

10.1002/jnr.23335 article EN Journal of Neuroscience Research 2014-01-27

10.1016/j.jpeds.2017.10.013 article EN The Journal of Pediatrics 2017-12-07

10.1016/0022-5088(91)90055-9 article EN Journal of the Less Common Metals 1991-06-01
Coming Soon ...